UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Head & neck, 2005-10, Vol.27 (10), p.843-850

2005

Volltextzugriff (PDF)

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Modern pathology, 2002-12, Vol.15 (12), p.1366-1373

2002

Volltextzugriff (PDF)

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

The New England journal of medicine, 2003-11, Vol.349 (22), p.2091-2098

2003

Volltextzugriff (PDF)

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2004-05, Vol.350 (19), p.1937-1944

2004

Volltextzugriff (PDF)

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3972-3978

2003

Volltextzugriff (PDF)

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

Journal of clinical oncology, 2002-03, Vol.20 (5), p.1167-1174

Minsky, B. D.

2002

Volltextzugriff (PDF)

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

International journal of radiation oncology, biology, physics, 2000-08, Vol.48 (1), p.7-16

2000

Volltextzugriff (PDF)

Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients

JNCI : Journal of the National Cancer Institute, 2006-04, Vol.98 (7), p.441-450

2006

Volltextzugriff (PDF)

Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

The New England journal of medicine, 1998-12, Vol.339 (27), p.1979-1984

1998

Volltextzugriff (PDF)

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

International journal of radiation oncology, biology, physics, 1995-03, Vol.31 (5), p.1341-1346

1995

Volltextzugriff (PDF)

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2527-2539

1996

Volltextzugriff (PDF)

A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy

International journal of radiation oncology, biology, physics, 2004-03, Vol.58 (3), p.674-681

2004

Volltextzugriff (PDF)

The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial

Cancer epidemiology, biomarkers & prevention, 2001-08, Vol.10 (8), p.823-829

2001

Volltextzugriff (PDF)

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999

Archives of pathology & laboratory medicine (1976), 2000-07, Vol.124 (7), p.995-1000

2000

Volltextzugriff (PDF)

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study

International journal of radiation oncology, biology, physics, 1993-02, Vol.25 (3), p.391-397

1993

Volltextzugriff (PDF)

p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610

JNCI : Journal of the National Cancer Institute, 1997-01, Vol.89 (2), p.158-165

1997

Volltextzugriff (PDF)

Prevention of Second Primary Tumors With Isotretinoin in Patients With Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up

JNCI : Journal of the National Cancer Institute, 1994-01, Vol.86 (2), p.140-141

1994

Volltextzugriff (PDF)

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11

Journal of clinical oncology, 1990-09, Vol.8 (9), p.1543-1555

1990

Volltextzugriff (PDF)

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24

International journal of radiation oncology, biology, physics, 1997-03, Vol.37 (4), p.777-782

1997

Volltextzugriff (PDF)

Analysis of the probability and risk of cause-specific failure

International journal of radiation oncology, biology, physics, 1994-07, Vol.29 (5), p.1183-1186

1994

Volltextzugriff (PDF)

Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

Cancer, 1987-06, Vol.59 (11), p.1874-1881

1987

Volltextzugriff (PDF)

Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience

International journal of radiation oncology, biology, physics, 1989-09, Vol.17 (3), p.449-456

1989

Volltextzugriff (PDF)

Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03

International journal of radiation oncology, biology, physics, 1991, Vol.20 (1), p.21-28

1991

Volltextzugriff (PDF)

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long‐term results of the radiation therapy oncology group study 81‐17

Cancer, 1990-11, Vol.66 (9), p.1861-1868

1990

Volltextzugriff (PDF)

Statistical issues in tumor marker studies

Archives of pathology & laboratory medicine (1976), 2000-07, Vol.124 (7), p.1011-1015

2000

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(128)

Sprache

Englisch
(128)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(125)
Science & Technology
(125)
Humans
(117)
Oncology
(107)
Female
(71)
Male
(68)
Middle Aged
(60)
Biological And Medical Sciences
(57)
Medical Sciences
(57)
Adult
(42)
Aged
(40)
Radiology, Nuclear Medicine & Medical Imaging
(35)
Combined Modality Therapy
(29)
Carcinoma, Squamous Cell - Radiotherapy
(28)
Clinical Trials As Topic
(28)
Head And Neck Neoplasms - Radiotherapy
(26)
Prognosis
(25)
Tumors
(24)
Time Factors
(20)
Otorhinolaryngology. Stomatology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients

Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy

The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study

p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610

Prevention of Second Primary Tumors With Isotretinoin in Patients With Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24

Analysis of the probability and risk of cause-specific failure

Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience

Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long‐term results of the radiation therapy oncology group study 81‐17

Statistical issues in tumor marker studies

Suchergebnisse filtern